This is a non-core endpoint: only basic statistics are computed.

Psoriatic arthropathies, strict definition

M13_PSORIARTH_STRICT

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions M13_PSORIARTH_ICD10	4278
3. Check pre-conditions, main-only, mode, registry filters Registry filters: KELA reimbursements: KELA codes — ANY KELA reimbursements: ICD-10 — M07.1, M07.1L40.5, M07.2, M07.2L40.5, M07.3, M07.3L40.5 1 out of 7 registries used, show all original rules.	14
4. Check minimum number of events None	14
5. Include endpoints None	14
6. Filter based on genotype QC (FinnGen only)	14

Control definitions (FinnGen only)

Control conditions: not M13_PSORIARTH_ICD10

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF3

NAME	M13_PSORIARTH_STRICT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!M13_PSORIARTH_ICD10
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	M13_PSORIARTH_ICD10
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	ANY
KELA_REIMB_ICD	M07&L405\|M07[1-3]
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Psoriatic arthropathies, strict definition based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	-	-	-
Only index persons	-	-	-
Unadjusted period prevalence (%)
Whole population	-	-	-
Only index persons	-	-	-
Median age at first event (years)
Whole population	-	-	-
Only index persons	-	-	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14	-	10
Unadjusted period prevalence (%)	0.00	-	0.00
Median age at first event (years)	43.94	-	41.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3037467) Urinalysis macro (dipstick) panel - Urine

+∞

4.16

5.5

2.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

6.66

2.84

1.9

1.8

—

(36304419) Bacteria [Presence] in Urine

5.50

2.44

3.4

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5.50

2.44

1.9

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

6.13

2.33

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

5.01

2.16

2.1

2.0

—

(3023368) Bacteria identified in Blood by Culture

5.00

2.01

3.0

4.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3.95

1.75

9.1

5.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4.56

1.68

1.2

3.9

umol/l

3.8

5.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3.72

1.42

3.8

4.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3.19

1.18

4.8

3.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2.98

1.15

3.6

3.9

—

(40758558) Short blood count panel - Blood

2.62

0.99

7.5

8.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2.51

0.95

5.5

1.8

—

(3003694) ABO and Rh group [Type] in Blood

2.32

0.71

1.8

1.2

—

(40768804) Tissue Pathology biopsy report

1.73

0.46

1.6

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1.73

0.46

1.0

2.8

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.44

0.0

1.3

—

43.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.44

0.0

1.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

126

+∞

0.44

23.2

14.1

umol/l

88.4

80.7

0.17

126

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1.60

0.24

5.4

3.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1.35

0.24

6.2

7.8

mmol/l

1.2

—

(4010399)

0.00

0.22

0.0

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

129

+∞

0.22

20.9

9.6

u/l

39.4

28.6

1.11

124

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.00

0.22

0.0

1.2

—

222.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.22

0.0

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1.29

0.12

6.0

2.2

ug/l

252.0

172.8

—

(1761868) Lipid panel - Serum or Plasma

1.22

0.11

2.7

2.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

0.00

0.0

12.6

—

66.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.0

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.00

0.0

11.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

0.00

0.0

3.0

—

1.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(4094501)

0.00

0.0

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

2.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1.00

0.00

2.4

4.6

—

22.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

2.0

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.0

1.2

—

(3019060) Gas panel - Arterial blood

0.00

0.0

1.9

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

0.00

0.0

3.0

—

0.7

—

(1002224) Polysomnography panel

0.00

0.0

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

0.00

0.0

3.4

—

96.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_PSORIARTH_STRICT and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_PSORIARTH_STRICT.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: M13_PSORIARTH_STRICT – Psoriatic arthropathies, strict definition

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Psoriatic arthropathies, strict definition

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints